Advertisement
News
Advertisement

Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation

Tue, 10/26/2010 - 6:32am
Bio-Medicine.Org

MOUNTAIN VIEW, Calif., Oct. 26 /PRNewswire/ -- Based on its recent analysis of the prostate cancer diagnosis market, Frost & Sullivan recognizes Hybridyne Technologies, Inc. with the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year.

(Logo:  http://photos.prnewswire.com/prnh/20081117/FSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

ProxiScan™, recently approved by the FDA, is based on the compact cadmium-zinc-telluride (CZT) detector, which is the core enabling component for creating high resolution images. ProxiScan™ is unique because it differs from traditional scintillator-based SPECT gamma cameras by offering much higher spatial resolution. It emerges as a technology that can lead to a more accurate and timely diagnosis and vastly improve upon the treatment strategies used for patients, leading to improved cancer care.  

"This technology has the distinct advantages of being compact and less costly, while offering better image quality within a smaller field of view," explains Frost & Sullivan Industry Analyst Sangeetha Prabakar. "Not only does it provide effective and more accurate localization of cancer at an earlier stage, the device's compactness also allows more accurate imaging by targeting the desired imaging area."

Because of its compact design, ProxiScan™ can be used for trans-rectal imaging and intra-body cavity measurements, which were originally not possible with conventional gamma cameras. With ProxiScan™, the working distance between the gamma camera and prostate gland is greatly minimized. This allows urologists to obtain much better images of abnormal tissue with smaller amounts of the injected radioactive tracer.

"ProxiScan™'s spectrometer-mode imaging capabilities, c

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading